Methionine restriction reduces the chemosensitivity of central nervous system tumour cell lines

Anticancer Research

Volumn 29, Issue 8, 2009, Pages 3103-3108

  Najim, N ^a   Podmore, I D ^a   Mcgown, A ^a   Estlin, E J ^b  

^a UNIVERSITY OF SALFORD   (United Kingdom)

^b ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Cisplatin; CNS tumours; Cytotoxicity; Methionine; Methotrexate; Temozolomide

Indexed keywords

CISPLATIN; GLUTATHIONE; METHIONINE; METHOTREXATE; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; TEMOZOLOMIDE;

AMINO ACID METABOLISM; ARTICLE; CANCER RESISTANCE; CENTRAL NERVOUS SYSTEM TUMOR; CHILDHOOD CANCER; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; ENZYME ACTIVITY; GLIOMA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MEDULLOBLASTOMA; PRIORITY JOURNAL; RESTRICTION MAPPING; TUMOR CELL LINE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CELL PROLIFERATION; CEREBELLAR NEOPLASMS; CISPLATIN; DACARBAZINE; DNA MODIFICATION METHYLASES; DNA REPAIR ENZYMES; DRUG RESISTANCE, NEOPLASM; FLUOROMETRY; GLIOMA; GLUTATHIONE; HUMANS; MEDULLOBLASTOMA; METHIONINE; METHOTREXATE; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 68549099664     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Kokkinakis D, Hoffman R, Frenkel EP, Wick JB, Han Q and Xu M: Synergy between methionine stress and chemotherapy in the treatment of brain tumour xenografts in athymic mice. Cancer Res 61: 4017-4023, 2001. (Pubitemid 32720965)
2. 6-methylguanine-DNA methyltransferase by methionine in human tumour cells. Br J Cancer 75: 779-788, 1997. (Pubitemid 27110691)
3. 6-alkylguanine-DNA alkyltransferase which confer significant resistance of human glial tumour xenografts to treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea or temozolomide. Clin Cancer Res 7: 421-428, 2001. (Pubitemid 32183048)
4. Mineura K, Sasajima T, Sasajima H and Kowada M: Inhibition of methionine uptake by cis-diamminedichloroplatinum (II) in experimental brain tumours. Int J Cancer 67: 681-683, 1996. (Pubitemid 26300986)
5. Aw T, Ookhtens M and Kaplowitz N: Inhibition of glutathione efflux from isolated rat hepatocytes by methionine. J Biol Chem 259: 9355-9358, 1984. (Pubitemid 14060489)
6. Haskell C: Cancer Treatment. London, W.B Saunders Company, 1985.
7. Allegra C and Grem J: Cancer Principles and Practice of Oncology. Philadelphia, Lippincott-Raven, 1997.
8. Estlin E: Continuing therapy for childhood acute lymphoblastic leukaemia; clinical and cellular pharmacology of methotrexate, 6-mercaptopurine and 6-thioguanine. Cancer Treat Rev 27: 351-368, 2001.
9. 6-alkyl-DNA alkyltransferase activity in human cells and tumour tissues by restriction endonuclease inhibition. Cancer Res 47: 6229-6232, 1987. (Pubitemid 18011069)
10. Cereser C, Guichard J, Drai J, Bannier E, Garcia I and Boget S: Quantitation of reduced and total glutathione at the femtomole level by high-performance liquid chromatography with fluorescence detection: application to red blood cells and culture fibroblasts. J Chromatogr B Analyt Technol Biomed Life Sci 752: 123-132, 2001.
11. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J and Vistica D: New colorimetric cytotoxicity assay for anticancer drug screening. J Natl Cancer Inst 82: 1107-1112, 1990. (Pubitemid 20213250)
12. Monks A, Scudiero D, Skehan P, Shoemaker R, Paull K and Vistica D: Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumour cell lines. J Natl Cancer Inst 83:757-766, 1991.
13. Chou T and Talalay P: Quantitative Analysis of Dose-Effect Relationship: The Combined Effects of Multiple Drugs on Enzyme Inhibitors. New York, Pergamon Press, 1983.
14. Bocangel D, Finkelstein S, Schold SC, Bhakat K, Mitra S and Kokkinakis DM: Multifaceted resistance of glioma to temozolomide. Clin Cancer Res 8: 2725-2734, 2002.
15. Kokkinakis D, Schold SC and Nobori T: Effect of long-term depletion of plasma methionine on the growth and survival of human brain tumour xenografts in athymic mice. Nutr Cancer 29: 195-204, 1997. (Pubitemid 28063271)
16. Poirson-Bichat F, Bras Goncalves R, Miccoli L, Dutrillaux B and Poupon MF: Methionine depletion enhances the antitumoral efficacy of cytotoxic agents in drug-resistant human tumour xenografts. Clin Cancer Res 6: 643-653, 2000. (Pubitemid 30111490)
17. Cui Y, Konig J, Buchholz U, Spring H, Leier I and Keppler D: Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells. Mol Pharmacol 55: 929-937, 1999. (Pubitemid 29214613)
18. D'Atri S, Tentor L, Lacal PM, Graziani G, Pagain E and Benincasa E: Involvement of the mismatch repair system in temozolomide-induced apoptosis. Am Soci Pharmacol Exp Ther 54: 334-341, 1998.
19. Pavillard V, Nicolaou A, Double JA and Phillips RM: Methionine dependence of tumours: A biochemical strategy for optimizing paclitaxel chemosensitivity in vitro. Biochem Pharmacol 71: 772-778, 2006. (Pubitemid 43208833)